This website is intended for healthcare professionals only
Specialities

Specialities

Bladder Cancer
Breast Cancer
Colorectal Cancer
COVID-19
Dermatologic Cancers
Diagnostics and Screening
Gastrointestinal Cancers
Genitourinary Cancer
Gynecologic Cancers
Hematology
Hematologic Malignancies
Head and Neck Cancer
Immunotherapy
Leukemia
Lymphoma
Multiple Myeloma
Ovarian Cancer
Pancreatic Cancer
Lung Cancer
Prostate Cancer
Renal Cancer
Endocrine Cancers
Pediatric Oncology
Policy
Sarcoma
Supportive Cancer Care
Soft Tissue Tumors
Neuro-oncology
Pathology
Radiology
Radiotherapy
Rare Diseases
Search

Trending Topic

Comprehensive Anatomical Render Of Breast Cancer In A Human Female
8 mins

Trending Topic
Developed by Touch
Mark CompleteCompleted
BookmarkBookmarked

Where are we now: Clinical utility and challenges of circulating tumor DNA in breast cancer

Saumya Easaw, Antoinette R Tan, Arielle L Heeke

Circulating tumor DNA (ctDNA) has emerged as an innovative and minimally invasive tool in precision oncology. With a short half-life of 30–120 min, ctDNA provides real-time insight into tumor dynamics.1 In early-stage breast cancer, there is growing evidence supporting its potential for minimal residual disease (MRD) detection and recurrence monitoring. In metastatic breast cancer (MBC), ctDNA […]

touchREVIEWS in Oncology & Haematology. 2026;22(2):1–4:Online ahead of journal publication

Connect With Us:

Facebook
X (Twitter)
Instagram
Youtube
Linkedin
Download html Download html

EUROPEAN ONCOLOGY & HAEMATOLOGY – SUPPLEMENT 1 (HAEMATOLOGY) – 2016

SUPPLEMENT – HAEMATOLOGY 
Introducing the latest European Oncology & Haematology supplement Advancing Our Clinical Perspectives in Haematology – What is Your Approach? , discussing the identification and management of essential thrombocythaemia. This supplement covers proceedings of the 11th New Horizons in Haematology International Conference, 11 March 2016.
Hematology

Advancing Our Clinical Perspectives in Haematology – What is Your Approach?

10 mins

Evolution of Knowledge in Essential Thrombocythaemia Disease Presented by: Gunnar Birgegård Division of Medical Sciences, Haematology, Uppsala University, Uppsala, Sweden Essential thrombocythaemia (ET) is a serious disease with significant morbidity and mortality and can sometimes transform to acute myeloid leukaemia (AML).1–3 ET must be differentiated from other myeloproliferative conditions such as polycythemia vera (PV) and […]

medical illustration concept symbol as a group of human blood cells

Trending Topic
Developed by Touch
Mark CompleteCompleted
BookmarkBookmarked

New Adjuvant Treatment Modalities in Thrombotic Thrombocytopenic Purpura: A Review of Recent Clinical Trials

Luke Z Li, Wadie F Bahou

The first primary microangiopathic haemolytic anaemia was identified as thrombotic thrombocytopenic purpura (TTP) by Dr Moschowitz in 1924. At that time, the classic pentad of clinical features, still used today, included fever, erythrocyte fragmentation, thrombocytopenia, kidney injury and neurologic injury.1 It is now known that this disease is characterized by the deficiency of a disintegrin and metalloproteinase with thrombospondin-1-like […]

Advertisement
    • 2

    Journal Archive

    View All Issues

    Comprising articles contributed by renowned thought leaders, European Oncology & Haematology is a peer reviewed, free-to-access, bi-annual journal that aims to disseminate best practice through review articles addressing the most important and salient developments in the Oncological & Haematology field in practical terms.

    European Oncology & Haematology
    Frequency: Two print issues per year (Summer & Winter); ePub ahead of print throughout the year.
    Print ISSN: 2045-5275 Electronic ISSN: 2045-5283
    Indexing: EMBASE, Google Scholar, Genamics JournalSeek

    Latest articles videos and clinical updates - straight to your inbox

    Close Popup